(Q37798008)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923267%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Virus-like particles in vaccine development (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923267%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923267%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Manuel J T Carrondo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923267%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Paula Marques Alves

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923267%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Maria Candida M Mellado

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923267%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Leda R Castilho

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923267%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

1 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923267%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923267%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923267%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923267%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

1149-1176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923267%20AND%20SRC:MED&resulttype=core&format=json

Cloned Viral Protein Vaccine for Foot-and-Mouth Disease: Responses in Cattle and Swine

15 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Hepatitis B vaccines: protective efficacy and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Virus-like particles as immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Determinants of autoantibody induction by conjugated papillomavirus virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Virus-like particles-universal molecular toolboxes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Global control of hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

New immunization initiatives and progress toward the global control of hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Chapter 15: HPV vaccine use in the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Cloning and endonuclease mapping of the hepatitis B viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Cloning in Escherichia coli and physical structure of hepatitis B virion DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Expression of hepatitis B surface antigen gene in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Synthesis and assembly of hepatitis B virus surface antigen particles in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Molecular characterization of recombinant Hepatitis B surface antigen from Chinese hamster ovary and Hansenula polymorpha cells by high-performance size exclusion chromatography and multi-angle laser light scattering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Immunogenicity of a recombinant Pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Prophylactic HPV vaccines: reducing the burden of HPV-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

A review of human carcinogens--Part B: biological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Case-control study of human papillomavirus and oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Chapter 2: The burden of HPV-related cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

M2e-based universal influenza A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

The expression of hybrid HIV:Ty virus-like particles in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

A pilot phase II study of the safety and immunogenicity of HIV p17/p24:VLP (p24-VLP) in asymptomatic HIV seropositive subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Therapeutic vaccination for future management of HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

A vaccine against nicotine for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Analysis of Ebola virus and VLP release using an immunocapture assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

A method for in vitro assembly of hepatitis C virus core protein and for screening of inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Expression and self-assembly of virus-like particles of infectious hypodermal and hematopoietic necrosis virus in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Characterization of Rous sarcoma virus Gag particles assembled in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

The production of human papillomavirus type 16 L1 vaccine product from Escherichia coli inclusion bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Expression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation, renaturation, and self-assembly of virus-like particles in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Chaperone-mediated in vitro assembly of Polyomavirus capsids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Intrinsic glycosylation potentials of insect cell cultures and insect larvae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Protection against lethal challenge by Ebola virus-like particles produced in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Nucleocapsid- and virus-like particles assemble in cells infected with recombinant baculoviruses or vaccinia viruses expressing the M and the S segments of Hantaan virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Assembly of herpes simplex virus type 1 capsids using a panel of recombinant baculoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Synthesis of Newcastle disease virus (NDV)-like envelopes in insect cells infected with a recombinant baculovirus expressing the haemagglutinin-neuraminidase of NDV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Assembly of the T = 4 Nudaurelia capensis omega virus capsid protein, post-translational cleavage, and specific encapsidation of its mRNA in a baculovirus expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Large conformational changes in the maturation of a simple RNA virus, nudaurelia capensis omega virus (NomegaV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Heparin binding induces conformational changes in Adeno-associated virus serotype 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Advances in methods for the production, purification, and characterization of HIV-1 Gag-Env pseudovirion vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Generation of recombinant norovirus-like particles (VLP) in the human endothelial kidney cell line 293T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Overexpression of hepatitis B virus surface antigens including the preS1 region in a serum-free Chinese hamster ovary cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Production of hepatitis B virus surface antigen containing pre-S1 and pre-S2 domains by Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Antibody responses to preS components after immunization of children with low doses of BioHepB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Baculovirus as a highly efficient gene delivery vector for the expression of hepatitis delta virus antigens in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Baculovirus-mediated production of HDV-like particles in BHK cells using a novel oscillating bioreactor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Challenges in creating a vaccine to prevent hepatitis E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Oral immunogenicity of human papillomavirus-like particles expressed in potato

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Hepatitis B surface antigen (HBsAg) expression in plant cell culture: Kinetics of antigen accumulation in batch culture and its intracellular form

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

A DNA replicon system for rapid high-level production of virus-like particles in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Conformational analysis of hepatitis B surface antigen fusions in an Agrobacterium-mediated transient expression system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

A plant signal peptide-hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Chemical-based translational induction of luciferase expression: an efficient tool for in vivo screening of protein farnesylation inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

MATra - Magnet Assisted Transfection: combining nanotechnology and magnetic forces to improve intracellular delivery of nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

N/P ratio significantly influences the transfection efficiency and cytotoxicity of a polyethylenimine/chitosan/DNA complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Comparison of different commercially available cationic liposome-DNA lipoplexes: Parameters influencing toxicity and transfection efficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

pH dependent high transfection efficiency of mouse neuroblastomas using TransFectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

FuGENE 6 Transfection Reagent: the gentle power

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Tetracycline-inducible packaging cell line for production of flavivirus replicon particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Functional analysis of various promoters in lentiviral vectors at different stages of in vitro differentiation of mouse embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Critical relationship between glycosylation of recombinant lutropin receptor ectodomain and its secretion from baculovirus-infected insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Cell density effect in the baculovirus-insect cells system: a quantitative analysis of energetic metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Baculovirus expression of the human papillomavirus type 16 capsid proteins: detection of L1-L2 protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Effect of re-feed strategies and non-ammoniagenic medium on adenovirus production at high cell densities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Modeling and optimization of the baculovirus expression vector system in batch suspension culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Effect of ammonia production on intracellular pH: Consequent effect on adenovirus vector production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Improving baculovirus production at high cell density through manipulation of energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Transcriptional profiling of batch and fed-batch protein-free 293-HEK cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Virus-like particle production at low multiplicities of infection with the baculovirus insect cell system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Continuous beta-galactosidase production in insect cells with a p10 gene based baculovirus vector in a two-stage bioreactor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Baculovirus expression system scaleup by perfusion of high-density Sf-9 cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Differential protein expression following low temperature culture of suspension CHO-K1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Scale-up of virus-like particles production: effects of sparging, agitation and bioreactor scale on cell growth, infection kinetics and productivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6 cell culture under sparging conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Effects of oxygen on recombinant protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Scaleable purification process for gene therapy retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Partial purification of intracellular murine sarcoma-leukemia virus RNA species by membrane filtration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Rapid purification of extracellular and intracellular Moloney murine leukemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Downstream processing of triple layered rotavirus like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Purification of recombinant rotavirus VP7 glycoprotein for the study of in vitro rotavirus-like particles assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Towards purification of adenoviral vectors based on membrane technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Purification of recombinant baculoviruses for gene therapy using membrane processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Downstream processing of viral vectors and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Quantification of rotavirus-like particles by gel permeation chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Sodium dodecyl sulfate-capillary gel electrophoresis analysis of rotavirus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Monitoring virus-like particle and viral protein production by intact cell MALDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

In situ 2D fluorometry and chemometric monitoring of mammalian cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Advances in on-line monitoring and control of mammalian cell cultures: Supporting the PAT initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

The coming of age of virus-like particle vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Coupling of antibodies via protein Z on modified polyoma virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Virus-like particles as a modular system for novel vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Virus-like particles: passport to immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Incorporation of dengue virus replicon into virus-like particles by a cell line stably expressing precursor membrane and envelope proteins of dengue virus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Virus-like particles as quantitative probes of membrane protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Cell-free assay of G-protein-coupled receptors using fluorescence polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Low pH-triggered model drug molecule release from virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Virus-like particle and viral vector production using the baculovirus expression vector system/insect cell system: adeno-associated virus-based products

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Growth rate control in fed-batch cultures of recombinant Saccharomyces cerevisiae producing hepatitis B surface antigen (HBsAg)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Co-expression of the hepatitis B surface and core antigens using baculovirus multiple expression vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Escherichia coli-based cell-free synthesis of virus-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Increased Hepatitis B surface antigen production by recombinant Aspergillus niger through the optimization of agitation and dissolved oxygen concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Assembly of physalis mottle virus capsid protein in Escherichia coli and the role of amino and carboxy termini in the formation of the icosahedral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Optimization of chimeric HIV-1 virus-like particle production in a baculovirus-insect cell expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Optimum conditions for production and purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Effect of MOI ratio on the composition and yield of chimeric infectious bursal disease virus-like particles by baculovirus co-infection: deterministic predictions and experimental results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Interior surface modification of bacteriophage MS2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Production in Saccharomycescerevisiae of MS2 virus-like particles packaging functional heterologous mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Assembly and biological and immunological properties of Newcastle disease virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Norovirus capsid protein expressed in yeast forms virus-like particles and stimulates systemic and mucosal immunity in mice following an oral administration of raw yeast extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

E. coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Display of neutralizing epitopes of Canine parvovirus and a T-cell epitope of the fusion protein of Canine distemper virus on chimeric tymovirus-like particles and its use as a vaccine candidate both against Canine parvo and Canine distemper

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Large scale production and downstream processing of a recombinant porcine parvovirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Production of hybrid double- or triple-layered virus-like particles of group A and C rotaviruses using a baculovirus expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Synthesis of rotavirus-like particles in insect cells: comparative and quantitative analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Production of rotavirus-like particles in Spodoptera frugiperda larvae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Assembly of SIV virus-like particles containing envelope proteins using a baculovirus expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Simian virus 40 VP1 capsid protein forms polymorphic assemblies in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Induction of heterosubtypic immunity to influenza virus by intranasal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Induction of long-term protective immune responses by influenza H5N1 virus-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Swine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Influenza vaccines based on virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Native display of complete foreign protein domains on the surface of hepatitis B virus capsids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Recombinant hepatitis B virus core particles: association, dissociation and encapsidation of green fluorescent protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

HBV core particles as a carrier for B cell/T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Universal influenza A vaccine: optimization of M2-based constructs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Protective immune responses against foot-and-mouth disease virus by vaccination with a DNA vaccine expressing virus-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Recombinant dengue virus type 2 envelope/hepatitis B surface antigen hybrid protein expressed in Pichia pastoris can function as a bivalent immunogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Virus-like particles as HIV-1 vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Influenza virus-like particles as an antigen-carrier platform for the ESAT-6 epitope of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Characterization of virus-like particle assembly for DNA delivery using asymmetrical flow field-flow fractionation and light scattering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Parvovirus B19 empty capsids as antigen carriers for presentation of antigenic determinants of dengue 2 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Versatile RHDV virus-like particles: incorporation of antigens by genetic modification and chemical conjugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

SV40 pseudovirions as highly efficient vectors for gene transfer and their potential application in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Presentation of functional foreign peptides on the surface of SV40 virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Anion-exchange membrane chromatography for purification of rotavirus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115

Stochastic simulation of protein expression in the baculovirus/insect cells system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.115